Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
about
Ratios of involved nodes in early breast cancer.RELATIVE EFFECTIVENESS IN BREAST CANCER TREATMENT: A HEALTH PRODUCTION APPROACHDescriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence.Age-specific cancer survival in Estonia: recent trends and data quality.The association of mood disorders with breast cancer survival: an investigation of linked cancer registration and hospital admission data for South East EnglandDo pre-diagnosis primary care consultation patterns explain deprivation-specific differences in net survival among women with breast cancer? An examination of individually-linked data from the UK West Midlands cancer registry, national screening proRacial/ethnic differences in early detection of breast cancer: a study of 250,985 cases from the California Cancer Registry.Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.Characteristics, survival, and related factors of newly diagnosed colorectal cancer patients refusing cancer treatments under a universal health insurance program.The value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer.Factors associated with lung cancer patients refusing treatment and their survival: a national cohort study under a universal health insurance in Taiwan.Expensive cancer drugs: a comparison between the United States and the United Kingdom.Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data.How might healthcare systems influence speed of cancer diagnosis: a narrative review.Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United kingdom.Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership.Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial.Socioeconomic disparity in survival after breast cancer in ireland: observational study.Interventions to increase the uptake of mammography amongst low income women: a systematic review and meta-analysis.Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of EnglandPopulation-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths.Do reproductive factors influence T, N, and M classes of ductal and lobular breast cancers? A nation-wide follow-up study.Facilitators and barriers to help-seeking for breast and cervical cancer symptoms: a qualitative study with an ethnically diverse sample in London.Interventions to promote cancer awareness and early presentation: systematic review.Delays in treating endometrial cancer in the South West of EnglandThe utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review.Factors affecting survival of women diagnosed with breast cancer in El-Minia Governorate, EgyptStage at diagnosis and early mortality from cancer in England.Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumorsPredictors of early death in female patients with breast cancer in the UK: a cohort study.New analysis reexamines the value of cancer care in the United States compared to Western EuropeBreast cancer awareness and barriers to symptomatic presentation among women from different ethnic groups in East London.Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancerIntegrated analysis of differentially expressed genes in breast cancer pathogenesis.Association of socioeconomic status with treatment delays, disease activity, joint damage, and disability in rheumatoid arthritis.Ethnicity, deprivation and screening: survival from breast cancer among screening-eligible women in the West Midlands diagnosed from 1989 to 2011.The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC).Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute?Distinct Small RNA Signatures in Extracellular Vesicles Derived from Breast Cancer Cell LinesBreast screening review--a radiologist's perspective.
P2860
Q24796013-B02035B6-98CE-47E5-A521-0733442311CDQ28073800-E3C343C7-D933-4074-950E-F5888A49E3EEQ30248287-BF311BD2-C193-419B-AF00-ED3743B6214FQ30985736-266A109C-EDB1-4B54-8C6E-77029B6520EFQ31029367-020E7EFE-148C-4A4C-A741-A74CA149EFD0Q31165270-A803C5C7-E44D-4612-9F10-5AAE51E6FBA5Q33710787-171E84D3-AA2B-4D83-85D3-502A3EFA362FQ33779753-FA794ECB-F149-463D-8419-1B8B5EA2E4B9Q33811632-42F07588-F932-4532-A91C-DE36A50122F3Q33822314-EDC706A5-F402-40BD-B512-3086E993B030Q33856023-98770D07-8D84-4D18-BB36-26F6298F333CQ33922623-23363C9B-BED7-454F-8F10-8B54C303595BQ33928596-94085B5A-EBDD-40E9-BA04-1C11EA1480F8Q34012398-A22AB913-A24A-47E6-BE58-E2B51C42601AQ34123797-4BC93C0C-F638-4B4E-97FB-4736694AF818Q34279558-CAEBF453-CEB9-4558-822C-0EA31D9BA010Q34432389-66A0263F-7A95-40A4-9031-710D0ECBA93DQ34456663-20228071-4186-40F9-9F5B-0C008A25A0FAQ34602244-C46C2755-D1B8-4B67-A7F1-55CC4741D5BFQ34627936-CD8906CE-A861-40F3-9433-E7E78194FAFCQ34745958-03A5C443-270B-424F-BF09-0FBDDF83608BQ34755230-1985AD3B-0143-4DDC-852A-09BE32E763ABQ34807021-161FAEDC-39B2-4992-8ACC-263AC7C676D4Q35015724-7209FBCF-E5B9-46AF-A057-B8A7A50EF2C1Q35034745-1734EDD3-1FD9-40D8-A6F7-092B8E8C1F2DQ35043809-930AEFEF-AE12-467F-9547-7491A3A2476AQ35127890-306355B9-8923-4CD5-B449-A4C3FE1F0E99Q35275282-F84469AB-700B-40A7-A949-4C25E14BF75FQ35486383-9A62A81A-BD9D-488B-8D0E-AA2372757E5AQ35583407-AE510C44-690C-4502-838F-C9562CA5663DQ35621404-7DFF4367-3C96-44A8-B744-715D3F57BCA6Q35623069-26333292-D041-48E1-8534-BFAD2E82847FQ35669141-6D385BDD-BE22-477D-AF61-9F0363EF5781Q35758109-13F7BFD0-B03B-459D-BD7E-C35F4A3B6DC2Q35788276-49DF941E-95B8-4B5D-A8C1-62E229F2DD4CQ35909580-B6D81EAE-EC93-4704-932C-A4AE98066D55Q35930745-32D7CF31-2009-4F18-86FD-A767A016ABD1Q35982411-C92901F3-6235-4D8F-8B7E-726867332815Q36118327-0EEC3EF5-8B32-46F7-9445-33BCC17FC180Q36326154-19F2323D-C0F7-429D-A0A8-FFF2E581BB69
P2860
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
description
im September 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 September 2003
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2003
@uk
name
Stage at diagnosis is a key ex ...... cancer survival across Europe
@en
Stage at diagnosis is a key ex ...... cancer survival across Europe
@nl
type
label
Stage at diagnosis is a key ex ...... cancer survival across Europe
@en
Stage at diagnosis is a key ex ...... cancer survival across Europe
@nl
prefLabel
Stage at diagnosis is a key ex ...... cancer survival across Europe
@en
Stage at diagnosis is a key ex ...... cancer survival across Europe
@nl
P2093
P50
P356
P1476
Stage at diagnosis is a key ex ...... cancer survival across Europe
@en
P2093
Carmen Martinez
Claudia Allemani
EUROCARE Working Group
Franco Berrino
Jan Willem Coebergh
Janine Bell
Judith Youngson
Riccardo Capocaccia
Tiiu Aareleid
Timo Hakulinen
P304
P356
10.1002/IJC.11226
P577
2003-09-01T00:00:00Z